KDM4C and prostate carcinoma: SD70 16, a reported inhibitor of ligand and genotoxic stress-inducetranslocationsin prostate cancer and which was later identified to inhibit KDM4C,59 was a weak TET inhibitor (35–55% at 100μM SD70 16).